Showing results (481-490 of 1,684) with videos related to
Sort By:
Pageof 169
Acta Geneticae Medicae Et Gemellologiae|January 1, 1979
The Aberdeen Obstetric Data BankB Thompson, M Samphier, M H HallActa Pharmacologica Et Toxicologica|September 1, 1984
Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitroH Hall, S O Ogren, L FlorvallInternal Medicine Journal|September 25, 2020
Medical and surgical treatment of thyroid eye diseaseAnthony J H Hall, Duncan J ToplissBiotechnology and Bioengineering|September 18, 2024
Active diagnostic ingredients (ADIs) for PCR: A mini-bioreactor producing dNTPs with silica immobilized R5-kinasesAnna R Bird, Elizabeth A H HallMethods in Enzymology|February 3, 2009
Monitoring the role of autophagy in C. elegans agingAlicia Meléndez, David H Hall, Malene HansenJournal of Neuroimmunology|July 2, 2019
Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C]PBR28 positron emission tomographyA Forsberg, J Lampa, J Estelius, et al.European Journal of Nuclear Medicine|May 1, 1997
Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomographyJ T Kuikka, K K Akerman, J Hiltunen, et al.Synapse (New York, N.Y.)|April 1, 1995
Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporterK A Bergström, C Halldin, J T Kuikka, et al.Journal of Neurochemistry|August 1, 1987
Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenylC D Arnett, J S Fowler, R R MacGregor, et al.European Journal of Nuclear Medicine|February 7, 2001
Metabolism of [123I]epidepride may affect brain dopamine D2 receptor imaging with single-photon emission tomographyK A Bergström, M Yu, J T Kuikka, et al.Pageof 169